Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AIG Orion Venture Capital Fund was a venture capital firm established in 1999 as a partnership between American International Group (AIG) and Israeli investment professionals. The fund specialized in early-stage investments within the Israeli technology and life sciences sectors, with a significant focus on biotechnology and medical devices. Backed by high-profile limited partners including Microsoft, Comcast, and the World Bank, it was recognized as one of the most successful Israeli venture funds of its era. Its portfolio featured notable healthcare companies such as Given Imaging, a leader in capsule endoscopy, and the genomics-based drug discovery company Compugen. The fund is currently inactive, having successfully completed its investment lifecycle and divested its holdings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AIG Orion Venture Capital Fund.